07:19 EST Olema Oncology (OLMA) up 13% at $11.40 after entering supply pact with Novartis
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OLMA:
- Olema Oncology, Novartis enter clinical trial collaboration and supply agreement
- Olema Oncology reports Q3 EPS (60c), consensus (58c)
- OLMA Earnings this Week: How Will it Perform?
- Olema Oncology presents preclinical data on anti-tumor activity for OP-3136
- Olema Oncology to present multiple posters at EORTC-NCI-AACR